Evaluasi kinerja apotek menggunakan pendekatan balanced scorecard
Journal of Pharmacy and Tropical Issues · 23.10.2026 · 6 (6) · 500-509
DOI: 10.56922/pti.v6i6.28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Tropical Issues, online erschienen am 23.10.2026. Verfasst von Indri Tri Astuti und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pharmacies face increasingly intense competition; therefore, performance measurement cannot focus solely on financial aspects but must also consider the perspectives of customers, internal business processes, and learning and growth.
Purpose
To evaluate pharmacy performance using the Balanced Scorecard (BSC) approach.
Method
This is a quantitative descriptive study with a cross-sectional design, conducted at Telaga Medika Pharmacy in Grobogan, Central Java, in 2025. The independent variables are the performance indicators within each BSC category, while the dependent variable is the pharmacy's overall performance. The population and sample were determined separately for each BSC category, as each involves different measurement objects and data sources. For the financial perspective, all financial report data from the 2022–2024 period were used (total sampling). For the customer perspective, the population consisted of 12,600 customer transactions over the last three months; the sample size was calculated using the Slovin formula with a 10% margin of error (e = 0.1), resulting in a minimum sample of 99.21, which was rounded up to 100 respondents.
Results
The study indicates that the financial perspective is in a healthy state, with a Gross Profit Margin (GPM) of 23.31–24.00%, a Net Profit Margin (NPM) of 11.66–12.00%, and revenue growth exceeding 13% per year. However, the Inventory Turnover Ratio (ITOR)—at 6.00–7.00 times per year—remains below the ideal standard of 8–12 times per year. From the customer perspective, the overall result falls into the "very satisfied" category, with 51% of respondents reporting they are "very satisfied" and 49% "satisfied," with the "Assurance" dimension recording the highest score (4.25). The internal business process perspective shows a 98.07% medication availability rate, an 8.2% incidence of drug-related problems (DRPs), and 100% label completeness; however, the dispensing time for compounded prescriptions during peak hours (35.7 minutes) approaches the upper limit of the established standard. The learning and growth perspective indicates that all employees fall within the "satisfied" to "very satisfied" categories, with an improving trend observed over the three-month study period.
Conclusion
Overall, the pharmacy in question demonstrates strong performance across all four Balanced Scorecard (BSC) perspectives, with inventory turnover and the turnaround time for compounded prescriptions during peak hours identified as key areas requiring further improvement. Keywords: Balanced Scorecard; Performance Evaluation; Pharmacy; Pharmaceutical Management. Pendahuluan: Apotek menghadapi persaingan yang semakin ketat sehingga pengukuran kinerja tidak dapat hanya berfokus pada aspek keuangan, tetapi juga perlu mempertimbangkan perspektif pelanggan, proses bisnis internal, serta pembelajaran dan pertumbuhan. Tujuan: Untuk mengevaluasi kinerja apotek menggunakan pendekatan Balanced Scorecard (BSC). Metode: Penelitian deskriptif kuantitatif dengan desain cross-sectional. Penelitian ini dilakukan di Apotek Telaga Medika, Grobogan, Jawa Tengah, tahun 2025. Variabel bebas dalam penelitian ini adalah indikator kinerja pada masing-masing kategori BSC, sedangkan variabel terikat adalah kinerja apotek. Populasi dan sampel ditentukan berdasarkan masing-masing kategori BSC karena setiap kategori memiliki objek pengukuran dan sumber data yang berbeda. Pada perspektif keuangan, seluruh data laporan keuangan periode 2022-2024 digunakan sebagai sampel (total sampling). Pada perspektif pelanggan, populasi mencakup 12,600 transaksi pelanggan dalam tiga bulan terakhir; jumlah sampel ditentukan menggunakan rumus Slovin dengan margin of error 10% (e = 0.1), sehingga diperoleh sampel minimal sebesar 99.21 yang dibulatkan menjadi 100 responden. Hasil: Penelitian menunjukkan perspektif keuangan berada pada kondisi sehat, dengan GPM berkisar 23.31-24.00%, NPM 11.66-12.00%, dan pertumbuhan pendapatan di atas 13% per tahun, sedangkan ITOR (6.00-7.00 kali/tahun) masih berada di bawah standar ideal 8-12 kali/tahun. Perspektif pelanggan secara keseluruhan menunjukkan kategori sangat puas, dengan 51% responden sangat puas dan 49% puas, serta dimensi Assurance mencatat skor tertinggi (4,25). Perspektif proses bisnis internal menunjukkan tingkat ketersediaan obat 98.07%, kejadian DRP 8.2%, dan kelengkapan label 100%, meskipun dispensing time resep racikan pada jam sibuk (35.7 menit) mendekati batas atas standar. Perspektif pembelajaran dan pertumbuhan menunjukkan seluruh karyawan berada pada kategori puas hingga sangat puas dengan tren yang membaik selama tiga bulan pengamatan. Simpulan: Secara keseluruhan, apotek terkait menunjukkan kinerja yang baik pada keempat perspektif BSC dengan perputaran persediaan dan kecepatan pelayanan resep racikan pada jam sibuk menjadi area utama yang masih memerlukan perbaikan. Kata Kunci: Apotek; Balanced Scorecard (BSC); Evaluasi Kinerja; Manajemen Kefarmasian.
Zitieren
APA
Astuti, I. T., Suriyadi, A., & Jayanti, E. (2026). Evaluasi kinerja apotek menggunakan pendekatan balanced scorecard. Journal of Pharmacy and Tropical Issues, 6(6), 500-509. https://doi.org/10.56922/pti.v6i6.28
Vancouver
Astuti IT, Suriyadi A, Jayanti E. Evaluasi kinerja apotek menggunakan pendekatan balanced scorecard. Journal of Pharmacy and Tropical Issues. 2026;6(6):500-509. doi:10.56922/pti.v6i6.28
BibTeX
@article{Astuti2026,
author = {Astuti, Indri Tri and Suriyadi, Ahmad and Jayanti, Emma},
title = {Evaluasi kinerja apotek menggunakan pendekatan balanced scorecard},
journal = {Journal of Pharmacy and Tropical Issues},
year = {2026},
volume = {6},
number = {6},
pages = {500--509},
doi = {10.56922/pti.v6i6.28}
}
EUVIMED